Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence

Clinical Cancer Research

Volumn 2, Issue 2, 1996, Pages 277-285

  Tilley, Wayne D ^a   Buchanan, Grant ^a   Hickey, Theresa E ^a   Bentel, Jacqueline M ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; TUMOR GROWTH;

EID: 0029915052     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Boring, C. C., Squires, T. S., and Tong, T. Cancer statistics, 1993. CA Cancer J. Clin., 43: 7-26, 1993.
2. Santen, R. J. Clinical review 37: endocrine treatment of prostate cancer. J. Clin. Endocrinol. Metab., 75: 685-689, 1992.
3. Kozlowski, J. M., Ellis, W. J., and Grayhack, J. T. Advanced prostatic carcinoma: early v's late endocrine therapy. In: G. L. Andriole and W. J. Catalona (eds.), The Urologic Clinics of North America, pp. 15-24. Philadelphia: W. B. Saunders Co., 1991.
4. O'Malley, B. The steroid receptor superfamily: more excitement predicted for the future. Mol. Endocrinol., 4: 363-369, 1990.
5. Tilley, W. D., Marcelli, M., Wilson, J. D., and McPhaul, M. J. Characterization and expression of a cDNA encoding the human androgen receptor. Proc. Natl. Acad. Sci. USA, 86: 327-331, 1989.
6. Tilley, W. D., Wilson, C. M., Marcelli, M., and McPhaul, M. J. Androgen receptor gene expression in human prostate carcinoma cell lines Cancer Res., 50, 5382-5386, 1990.
7. Quarmby, V. E., Beckman, W. J., Cooke, D. B., Lubahn, D. B., Joseph, D. R., Wilson, E. M., and French, F. S. Expression and localization of androgen receptor in the R-3327 Dunning rat prostatic adenocarcinoma. Cancer Res., 50: 735-739, 1990.
8. Visakorpi, T., Hyytinen, E., Koivisto, P., Tanner, M., Keinanen, R., Palmberg, C, Palotie, A., Tammela, T., Isola, J., and Kaltioniemi, O. P. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat. Genet., 9: 401-406, 1995.
9. Klocker, H., Culig, Z., Hobisch, A., Cato, A. C. B , and Bartsch, G. Androgen receptor alterations in prostatic carcinoma. Prostate, 25: 266-273, 1994.
10. Thompson, T. C. Growth factors and oncogenes in prostate cancer. Cancer Cells, 2: 345-354, 1990.
11. van der Kwast, T. H., Schalken, J., de Winter, J. A., van Vroonhoven, C. C., Mulder, E., Boersma, W., and Trapman, J. Androgen receptors in endocrine-therapy-resistant human prostate cancer. Int. J. Cancer, 48: 189-193, 1991.
12. Newmark, J. R., Hardy, D. O., Tonb, D. C., Carter, B. S., Epstein, J. I., Isaacs, W. B , Brown, T. R., and Barrack, E. R. Androgen receptor gene mutations in human prostate cancer. Proc. Natl. Acad. Sci. USA. 89: 6319-6323, 1992.
13. Culig, Z., Hobisch, A., Cronauer, M. V., Cato, A. C. B , Hittmair, A., Radmayr, C., Eberle, J., Bartsch, G., and Klocker, H. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Mol. Endocrinol., 7: 1541-1550, 1993.
14. Gaddipati, J. P., Mcleod, D. G., Heidenberg, H. B., Sesterhenn, I. A., Finger, M. J., Moul, J. W., and Srivastava, S. Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers. Cancer Res., 54: 2861-2864, 1994.
15. Suzuki, H., Sato, N., Watabe, Y., Masai, M, Seino, S., and Shimazaki, J. Androgen receptor gene mutations in human prostate cancer. J. Steroid Biochem. Mol. Biol., 46: 759-765, 1993.
16. Taplin, M. E., Bubley, G. J., Shuster, T. D., Frantz, M. E., Spooner, A. E., Ogata, G K., Keer, H. N., and Balk, S. P. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J. Med., 332: 1393-1398, 1995.
17. Castagnaro, M., Yandell, D., Dockhorn-Dworniczak, Wolfe, H., and Poremba, C. Androgen receptor gene mutations and p53 gene analysis in advanced prostate cancer. Verh. Dtsch. Ges. Pathol., 77: 119-123, 1993.
18. Khoury, S. Staging of prostate cancer. In: S. Khoury, C. Chatelain. G. Murphy, and L. Denis (eds.), Urology: Prostate Cancer, pp. 149-153. France: FIIS, 1990.
19. Tilley, W. D., Lim-Tio, S. S., Horsfall, D. J., Aspinall, J. O., Marshall, V. R., and Skinner, J. M. Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: measurement by color video image analysis. Cancer Res., 54: 4096-4102, 1994.
20. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, pp. 9.14-9.23. Plainview, NY: Cold Spring Harbor Laboratory Press, 1989.
21. Marcelli, M., Tilley, W. D., Wilson, C. M., Griffin, J. E., Wilson, J. D., and McPhaul, M. J. Definition of the human androgen receptor gene structure permits the identification of mutations that cause androgen resistance: premature termination of the receptor protein at amino acid residue 588 causes complete androgen resistance. Mol. Endocrinol., 4: 1105-1116, 1990.
22. Lubahn, D. B., Brown, T. R., Simental, J. A., Higgs, H. N., Migeon, C. J., Wilson, E. M., and French, F. S. Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity. Proc. Natl. Acad. Sci. USA, 86: 9534-9538, 1989.
23. La Spada, A. R., Wilson, E., Lubahn, D., Harding, A., and Fischbeck, K. H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature (Lond.), 352: 77-79, 1991.
24. Hayashi, K. PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods. Applic., 1: 34-38, 1991.
25. Edwards, A., Voss, H., Rice, P., Civitello, A., Stegemann, J., Schwager, C., Zimmermann, J., Erfle, H., Caskey, C. T., and Ansorge, W. Automated DNA sequencing of the human HPRT locus. Genomics, 6: 593-608, 1990.
26. Orita, M., Suzuki, Y., Sekiya, T., and Hayashi, K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics, 5: 874-879, 1989.
27. Husmann, D. A., Wilson, C. M., McPhaul, M. J., Tilley, W. D., and Wilson, J. D. Antipeptide antibodies to two distinct regions of the androgen receptor localize the receptor protein to the nuclei of target cells in the rat and human prostate. Endocrinology. 126: 2359-2368, 1990.
28. Greenberg, N. M., Demayo, F., Finegold, M. J., Medina, D., Tilley, W. D., Aspinall, J. O., Cunha, G. R., Donjacour, A. A., Matusik, R. J., and Rosen, J. M. Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. USA, 92: 3439-3443, 1995.
29. Shi, S R , Chaiwun, B., Young, L., Cote, R. J., and Taylor, C. R. Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalin-fixed paraffin sections. J Histochem. Cytochem., 41:1599-1604, 1993.
30. Veldscholte, J. C. R., Kuiper, G. G., Jenster, G., Benrevoets, C., Claassen, E., vanRooij, H. C., Trapman, J., Brinkmann, A O., and Mulder, E. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem. Biophys Res. Commun. 173: 534-540, 1990.
31. Schoenberg, M. P., Hakimi, J. M., Wang, S. P., Bova, G. S., Epstein, J. I., Fischbeck, K. H., Isaacs, W. B., Walsh, P. C., and Barrack, E. R. Microsatellite mutation (CAG(24-18)) in the androgen receptor gene in human prostate cancer. Biochem. Biophys. Res. Commun., 198: 74-80, 1994.
32. Jenster, G., Vanderkorput, H. A. G. M., Trapman, J., and Brinkmann, A. O. Identification of two transcription activation units in the N-terminal domain of the human androgen receptor. J. Biol. Chem., 270: 7341-7346, 1995.
33. Cariello, N. F., and Skopek, T. R. Analysis of mutations occurring at the human HPRT locus. J. Mol. Biol., 231: 41-57, 1993.
34. Zoppi. S., Marcelli, M., Deslypere, J. P., Griffin, J. E., Wilson, J. D., and McPhaul, M. J. Amino acid substitutions in the DNA-binding domain of the human androgen receptor are a frequent cause of receptor-binding positive androgen resistance. Mol. Endocrinol., 6: 409-415, 1992.
35. Takahashi, H., Furusato, M., Allsbrook, W. C., Nishii, H., Wakui, S., Barrett, J. C., and Boyd, J. Prevalence of androgen receptor gene mutations in latent prostatic carcinomas from Japanese men. Cancer Res., 55: 1621-1624, 1995.
36. Thigpen, A. E., Davis, D. L., Milatovich, A., Mendonca, B. B., Imperato, M. J., Griffin, J. E., Francke, U., Wilson, J. D., and Russell, D. W. Molecular genetics of steroid 5 alpha-reductase 2 deficiency. J. Clin. Invest., 90: 799-809, 1992.
37. Mazars, R., Spinardi, L., BenCheikh, M., Simony Lafontaine, J., Jeanteur, P., and Theillet, C. p53 mutations occur in aggressive breast cancer. Cancer Res., 52: 3918-3923, 1992.
38. Mebust, W. K., Holtgrewe, H. L., Cockett, A. T. K., and Peters, P. C. Transurethral prostatectomy: immediate and postoperative complications: a cooperative study of 13 participating institutions evaluating 3,885 patients. J. Urol., 141: 243-247, 1989.
39. McPhaul, M. J., Marcelli, M., Zoppi, S., Wilson, C. M., Griffin, J. E., and Wilson, J. D. Mutations in the ligand-binding domain of the androgen receptor gene cluster in two regions of the gene. J. Clin. Invest , 90: 2097-2101, 1992.
40. Sultan, C., Lumbroso, S., Poujol, N., Belon, C., Boudon, C., and Lobaccaro, J. M. Mutations of androgen receptor gene in androgen insensitivity syndromes. J. Steroid Biochem. Mol. Biol., 46: 519-530, 1993.
41. Scher, H. I., and Kelly, W. K. Flutamide withdrawal syndrome - its impact on clinical trials in hormone-refractory prostate cancer. J. Clin. Oncol., 11: 1566-1572, 1993.
42. Coetzee, G. A., and Ross, R. K. Prostate cancer and the androgen receptor. J. Natl. Cancer Inst. 86: 872-873, 1994.
43. Chamberlain, N. L., Driver, E. D., and Miesfeld, R. L. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res., 22: 3181-3186, 1994.
44. Mhatre, A. N., Trifiro, M. A., Kaufman, M., Kazemiesfarjani, P., Figlewicz, D., Rouleau, G., and Pinsky, L. Reduced transcriptional regulatory competence of the androgen receptor in x-linked spinal and bulbar muscular atrophy. Nat. Genet., 5: 184-188, 1993.
45. Marcelli, M., Titley, W. D , Zoppi, S., Griffin, J. E., Wilson, J. D., and McPhaul, M. J. Androgen resistance associated with a mutation of the androgen receptor at amino acid 772 (Arg-Cys) results from a combination of decreased messenger ribonucleic acid levels and impairment of receptor function. J. Clin. Endocrinol. Metab., 73: 318-325, 1991.
46. Shan, L. X., Rodriguez, M. C., and Janne, O. A. Regulation of androgen receptor protein and mRNA concentrations by androgens in rat ventral prostate and seminal vesicles and in human hepatoma cells. Mol. Endocrinol., 4: 1636-1646, 1990.